%0 Journal Article
%T The ethical case for placebo control in HIV-cure-related studies with ART interruption.
%A Magalhaes M
%A Kuritzkes DR
%A Eyal N
%A Magalhaes M
%A Kuritzkes DR
%A Eyal N
%J J Virus Erad
%V 8
%N 3
%D Sep 2022
%M 36106155
%F 5.148
%R 10.1016/j.jve.2022.100084
%X Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.